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Haptens, such as drugs and other low molecular weight
chemicals, become immunogenic only upon binding to
proteins. Among antibiotics, penicillins are most com-
monly used for the treatment of bacterial infections and
constitute a typical example of allergy inducing drugs in
humans. Previous work on their immunologic properties
focused mainly on the examination of IgE-mediated
hypersensitivity reactions; however, drug-specific T cell
reactions are also involved in causing a serious allergic
inflammatory response. This review will focus on the
interaction between antibiotic molecules and penicillin-
specific T lymphocytes in humans. Experimental data
accumulated so far on the reactivity of T cells with
Adverse reactions to antibiotics may cause serious problemsin practical medicine. On the one hand, such reactionsinclude side-effects due to the toxicity of the drug. Onthe other hand, the induction of drug-specific immunereactions may result in immediate and delayed types of
hypersensitivity.
In analogy to other chemical haptens, the ability of any drug to
induce an immune response depends on its reactivity with proteins.
Thus, drugs like β-lactam antibiotics, which easily form covalent bonds
with free amino groups, are generally more immunogenic than, for
example, sulfonamides, which are intrinsically unreactive and require
cellular metabolism to produce reactive intermediates (Park et al, 1987).
The molecular targets of such haptenation processes may be soluble
or cell-bound proteins, including major histocompatibility complex
(MHC) molecules and the associated peptides.
In the mouse, T cell responses to model haptens are induced by
haptenated peptides presented by MHC molecules to specific antigen
receptors of T lymphocytes (Nalefski and Rao, 1993; Martin and
Weltzien, 1994; Luescher et al, 1995); however, the nature of hapten
determinants, formed by drugs and other chemicals and relevant for
human T cells, has only recently begun to be intensively investigated.
Although the molecular interactions of chemical allergens with human
T cells bear similarities to the recognition of nominal peptide antigens,
they also exhibit particular characteristics and peculiarities. In this review
we will concentrate on recent developments in the understanding of
penicillin-specific human T cell responses.
PENICILLINS AS ALLERGENS
Penicillins constitute a large family of compounds whose common
structural basis is a β-lactam ring condensed to a thiazolidine ring.
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penicillin G point to penicilloyl-modified, major histo-
compatibility complex-associated peptides as T cell epi-
topes. The recognition specificity of the respective T cell
receptors appears to be directed at both the backbone
and the specific side chain of penicillin. In contrast, the
sequence of the carrier peptides appears to contribute
little to the antigenic specificity, mainly as a holder for
the haptenic determinant. Finally, recent results demon-
strating the capacity of penicillins to modulate, in vitro,
the Th0/Th2 phenotype of established T cell clones
will be presented and discussed in relation to possible
therapeutic applications. Key words: haptens/penicilloyl-
peptides/T cell. J Invest Dermatol 110:203–206, 1998
Connected to this common backbone structure are characteristically
different amide-bonded side chains in every member of this class of
compounds. The β-lactam ring is a target for nucleophilic attack by
free amino groups of proteins, leading to ring opening and covalent
amide bonding of the penicilloyl group (Batchelor et al, 1965). The
penicilloyl configuration, where the hapten determinant is covalently
linked to ε-amino groups of lysine residues of proteins, constitutes
more than 90% of the reaction products between proteins (Fig 1), and
is also referred to as the major antigenic determinant for antibodies. It
plays a role in 75% of IgE mediated allergic reactions and is the target
for most other types of hypersensitivity reactions, including delayed
type hypersensitivity (Sullivan, 1993). Other conjugation products can
be formed by degradation of penicillin in solution to penicillenic or
penicilloic acid, which form disulfide bonds with sulfhydryl groups of
cysteine producing, respectively, penicillenyl- and penicillamine-pro-
tein conjugates (Fig 1). These so-called minor antigenic determinants
are present only at low abundance, but may also contribute to the
induction of IgE mediated reactions (Levine and Redmond, 1969).
PENICILLIN-SPECIFIC T CELL ACTIVATION IN ALLERGIC
INDIVIDUALS
Several experimental data support the involvement of T cell responses
in penicillin allergy. It has been demonstrated that peripheral blood
lymphocytes of penicillin allergic patients proliferate, in vitro, in response
to the appropriate β-lactam antibiotic. Antigen-specific T cell clones
isolated from such cultures were of the CD41 or CD81 phenotype
and secreted heterogeneous patterns of cytokines upon antigenic
stimulation (Brander et al, 1995). T lymphocytes in allergic skin lesions
were identified as mainly CD81 and when expanded in vitro they
expressed cytolytic activity against epidermal keratinocytes and autolog-
ous B cells upon cross-linking of their T cell receptor (TCR) (Hertl
et al, 1993), pointing to the skin as the target organ of drug-induced
CD81 T cells (Hertl and Merk, 1995); however, the majority of
penicillin-specific T lymphocytes, particularly if isolated from peripheral
blood, appear to be of the CD41 phenotype (Brander et al, 1995;
Padovan et al, 1996).
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Figure 1. Hapten determinants derived from b-lactam antibiotics. The
most common form of protein modification by penicillins results in the
penicilloyl configuration, formed upon opening of the lactam ring by an amide
bond to lysine ε-amino groups. This product represents a major antigenic
determinant for penicillin-specific immunoglobulins as well as T cells. Other
determinants may derive by the formation of disulfide bonds with cysteine
residues of proteins (penicillenyl or penicillamin determinants). Such minor
antigenic determinants only represent a minority of the haptenation products,
but may contribute to the induction of IgE mediated allergic responses.
Despite several recent studies on drug-reactive T cells (Kalish et al,
1994; Mauri-Hellweg et al, 1995; Zanni et al, 1997), questions on the
identity of the molecular structure of the antigenic epitopes involved
in these reactions are only beginning to be addressed.
Concerning their function as haptens, β-lactam antibiotics represent
a particularly convenient tool of investigation. The bicyclic thiazolidine/
β-lactam backbone is identical for all penicillins and distinguishes them
from other β-lactam antibiotics, e.g., cyclosporines. On the other
hand, many different side chains allow a detailed analysis of the fine
specificity of recognition by penicillin-specific TCR. Considering this,
numerous independent penicillin G (Pen G)-specific CD41 T cell
clones were analyzed for their capacity to proliferate in response to
Pen G, penicillin V (Pen V), and ampicillin (Amp), differing exclusively
in the region joining the phenyl group of the side chain with the β-
lactam ring. Typical patterns of reactivity are summarized in Fig 2(A–
D): the clones examined could be divided into four types, depending
on their sensitivity to subtle chemical variations in the side chain of
the antibiotic molecule. Among those, type I clones (Fig 2A), highly
specific for Pen G, and clones of type III (Fig 2C), showing a broad
cross-reaction, each with 35%, represented a majority (Padovan et al,
1996). The molecular epitope involved in this recognition was further
deduced from the fact that not even type III clones reacted to either
6-aminopenicillenic acid or cefaclor (Fig 2E). 6-aminopenicillenic acid
completely lacks a side chain whereas in cefaclor the thiazolidine
ring is replaced by a six-membered ring. The most straightforward
explanation of these data is that the antigenic determinant contacted
by the specific TCR is formed by the contributions of both the side
chain and the backbone structure of the penicillin molecule.
Experimental evidence suggested that the molecular constraints in
the presentation of Pen G are similar to those for nominal antigens.
The penicillin-specific T cell response is MHC restricted, with a strong
predominance of HLA-DR restriction for CD41 T cell clones (Padovan
et al, 1996). Moreover, penicillin can be presented to specific T cells
by glutaraldehyde-fixed autologous B cells, implying the covalent
formation of antigenic epitopes without requirement of intracellular
processing (Brander et al, 1995; Padovan et al, 1996). Such information
supported the idea of T cell activation as a consequence of TCR
interaction with penicillin-modified peptides bound in the grove of
surface MHC molecules. We indeed demonstrated the central role of
hapten-modified peptides in eliciting these immune responses by using
synthetic penicilloyl-peptides (Padovan et al, 1997). As shown in
Table I, T cell clones reactive to Pen G presented by homozygous
Figure 2. Reactivity of Pen G-induced T cell clones to different
penicillin derivatives. Proliferation of Pen G-specific T cell clones was
induced in the presence of Pen V and Amp, bearing small differences in the
side chain of the molecule. The T cell clones examined could be divided into
four groups, according to different patterns of cross-reactivity. The proliferative
response of one representative clone for each group is shown in (A)–(D); the
values of background proliferation of types I (A), II (B), III (C), and IV (D)
were 350, 670, 420, and 200 cpm, respectively. In order to identify the
molecular epitope interacting with those hapten-specific TCR, the most cross-
reactive clones (type III) were analyzed for the capacity to proliferate in response
to 6-aminopenicillenic acid and cefaclor. The first compound is a penicillin
derivative completely missing the side chain, whereas cefaclor is a cephalosporin
containing a 6-membered dihydrothiazine ring in the constant portion and
bearing a side chain identical to Amp. The lack of proliferative response against
these two compounds shown in (E), strongly indicates the need of both the
thiazolidine ring and the side chain of the penicillin molecule for the stimulation
of the TCR. Background proliferation in the absence of antigen was 400 cpm.
In all the experiments, autologous EBV-transformed B cells were used as
presenters. The proliferative response is expressed in cpm 3 103 and given as
the mean of duplicates; SD did not exceed 10% of the response.
Table I. Efficiency of Pen G-modified designer and natural
peptides in triggering T cell proliferation of clones Rl12 and
clone ES4.4
Peptides LD50 of proliferation (µM)
Name Sequence Rl12 ES4.4
– 1 – 1
PEP1a E A Y A K*A A S A A A A nr nr nr 0.6d
PEP2a E A Y A A A K*S A A A A nr 10c nr nr
PEP3a E A Y A A A A S A K*A A nr 0.1c nr nr
MCPb V P Y R Y L Q R R K*K*K*G K* nr 50c nt nt
a The 12mer polyalanine peptides PEP1, PEP2, and PEP3 contain Y in position P1 as
general DR anchor (Hammer at al, 1993), and S in P6 as a DRB1*0401-specific anchor
(McNicoll et al, 1995). E in position –2 was introduced to increased peptide solubility.
Each peptide contains a K residue in positions corresponding to TCR contact sites (Stern
et al, 1994). * indicates the position of the possible Pen G modification. 1/– indicates
whether or not peptide were modified with Pen G. nr, no reaction; nt, not tested.
b The sequence MCP 315–328, derived from the membrane cofactor protein, has been
described among the natural peptide eluted from DRB1*1101 molecules (Verreck et al,
1996). For this peptide the modification occurred on all K residues present in the sequence
(Kalbacher H, personal communication).
c Reactions of clone Rl12 to PEP2-Pen G and PEP3-Pen G were restricted by
DRB1*0401, whereas reactivity to MCP-Pen G was DRB1*1101 restricted. The efficiency
of T cell stimulation is expressed as concentration of peptide (µM) inducing 50%
of proliferation.
d Reaction of clone ES4.4 to PEP1-Pen G was restricted by DRB1*0401.
DRB1*0401 B cells, proliferated in response to designer peptides
containing the appropriate HLA-DR anchor residues and carrying a
lysine-bound penicilloyl group in specific TCR contact sites. In those
experiments a precise positioning of the hapten molecule on the
peptide backbone was required for optimal stimulation, and no
stimulation was induced by the unmodified peptides. Moreover, the
covalent modification by Pen G of peptide MCP 315–328, a natural
DRB1*1101 binder (Verreck et al, 1996), did confer antigenic proper-
ties for Pen G reactive T cells to this sequence (Table I). The
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Figure 3. The phenotype of clone BAM25 depends on the dose of Pen
G used for stimulation and other nonimmunogenic penicillin derivatives
can have a selective inhibitory activity. (A, B) Production of IL-4 and
IFN-γ induced by different concentrations of Pen G (u), Pen V (s), and
Amp (n). Cytokine production was measured by sandwich enzyme-linked
immunosorbent assay and the sensitivity of both assays was 20 pg/ml. Data are
expressed as pg/ml of secreted cytokine and given as mean of triplicates. (C,
D) Effect of Pen V and Amp on the response to Pen G. Pen G alone, at a
concentration of 0.25 mg/ml, was used as control. In the assay different
concentrations of Pen V and Amp were given on top of this fixed amount of
Pen G. Data are expressed as the amount of cytokines secreted in culture
supernatant, given as the mean of triplicates and represented as the percentage
of control. In all the experiments autologous EBV transformed B cells were
used as presenters.
cross-reactive recognition of Pen G-modified self-peptides as well as
of non-natural penicilloyl designer peptides or Pen G-modified whole
presenter cells, clearly indicates a carrier independence of these react-
ivities.
As previously discussed for trinitrophenyl (TNP) responses in the
mouse (Weltzien et al, 1995), and now formally proven for penicillin
hypersensitivity in humans, antigenic determinants generated by haptens
can derive from covalent modification of extra- or intracellular proteins
as well as of MHC-associated peptides. Considering the selectivity of
amino acid modifications by individual haptens, one might expect the
availability of modification sites on a protein to be very limited. Three-
dimensional structures and chemical factors are expected to further
reduce the accessibility of target amino acids for modification. In this
scenario, the direct haptenization of MHC-associated natural peptides
might be more relevant than previously thought. In the case of carrier
independent hapten recognition, specificity is defined mainly by the
positioning of modifyable amino acids in the MHC groove, and the
density of reactive epitopes for any given TCR on the surface of
antigen-presenting cells might be relatively high, compared with those
formed by nominal antigens. It is tempting to consider this as one of
the decisive factors in defining the allergic potential of haptens.
The role of minor antigenic determinants, like penicillenyl or
penicillamine groups (Fig 1), in inducing penicillin-specific cellular
responses, remains an open question. For a better understanding of the
immunopathology of these allergic reactions it would be relevant to
determine whether these structures can activate penicillin-specific
T cells.
MOLECULAR VIEWS OF PENICILLIN RECOGNITION
From the data presented above, the analogies of the immune recognition
of haptens in humans and mice are clearly evident. In both systems,
the activation of hapten-specific T cells is mediated by hapten-modified
peptides. The fact that the responses of the human T cell clones studied
in detail were carrier independent (Padovan et al, 1997) does not
exclude the existence of TCR contacting haptenic and peptidic
determinants at the same time; however, this latter way of recognition,
well documented for TNP responses in the mouse (Martin and
Weltzien, 1994), could be detected only as a consequence of in vitro
priming with TNP-modified peptides.
A molecular modeling of penicillin recognition by specific TCR
can be envisaged. It is likely that the thyazolidine ring and the phenyl
group of the side chain of the molecule rotate and dispose in the space
in order to be simultaneously recognized as such. The movement will
be certainly influenced by the flexibility of the side chain of the
penicillin derivative. The rotation may even result in the formation of
a big hydrophobic group contacting particular TCR sites (Garcia et al,
1996; Garboczi et al, 1996).
As with any other lymphocytes, hapten-specific cells are also selected
in the thymus in the absence of those chemical compounds. Cross-
reactivity to completely irrelevant antigens, leading to selection events,
might be a possible explanation; however, one could also imagine that
for a TCR in that environment, the recognition of a molecular volume
more than a precise chemical structure could be sufficient for the
transmission of a survival signal. If this is the case a selection event
might result from the interaction of hapten-specific TCR with particular
amino acid sequences bound to MHC molecules forming three-
dimensional structures that mimic the hapten determinant (Lepoittevin
and Leblond, 1997).
TH1/TH2 PHENOTYPES IN PENICILLIN ALLERGY
The activation of CD41 T cells by haptens plays a critical role in an
allergic inflammatory immune response. The subsequent differentiation
of T helper (Th) lymphocytes into Th1 or Th2 cells affects the
recruitment of the many other cell types participating in the response.
In both mice and men, immune activation events drive the differenti-
ation of naı¨ve Th lymphocytes into two distinct subsets of effector
cells, which are phenotypically and functionally different (Abbas et al,
1996). Th1 cells produce cytokines associated with inflammation, such
as interleukin (IL)-2 and interferon (IFN)-γ, and induce cell-mediated
immune responses. IL-4 and IL-5, in contrast, are characteristic for
the Th2 subset, which is associated with humoral immune responses
(Mossman and Sad, 1996). The predominance of Th1 responses in
organ-specific autoimmune diseases, like diabetis and thyroiditis, and
abnormal activation of Th2 responses in atopic diseases and bacterial
infections, are only some of the several examples where the immunopa-
thology is determined by the overproduction of a polarized pattern of
cytokines (Romagnani, 1994).
The functional Th1/Th2 dichotomy is likely to play a role also in
the allergic phenomena induced by penicillins, in particular with a
prevalence of Th2 responses in immediate hypersensitivity reactions
and of Th1 responses in delayed allergic phenomena. Evidence for this
has been found by measuring the cytokine profiles of T cell lines from
the peripheral blood of patients with penicillin-induced exanthems.
Cell lines from subjects suffering from bullous exanthems, one of the
clinical features of delayed type reactions, secreted high levels of IFN-
γ, whereas cells from patients with drug-induced urticaria produced
IL-4 (Merk and Hertl, 1996).
As part of the Th1/Th2 paradigm the selective differentiation of
either subset takes place during T cell priming, with the contribution
of several factors, e.g., antigen dose, cytokine environment, and the
nature and activation status of antigen-presenting cells (Constant and
Bottomly, 1997). Once this differentiation is achieved the status is
believed to be irreversible (Murphy et al, 1996). Biochemical differences
of the two subsets contribute to the irreversibility of this process. In
particular, it has been shown that loss of expression of the IL-12
receptor β chain in Th2 but not Th1 cells renders these cells
unresponsive to IL-12 signaling, which drives Th1 proliferation (Szabo
et al, 1995).
For some of our Pen G-specific T cell clones, we found an inducible
shift between Th0 and Th2 phenotypes, even after continuous culture
for over 1 y. The pattern of cytokines secreted by these clones was
flexible and depended on the dose of Pen G used for stimulation.
Thus, clone BAM25 was raised with a dose of Pen G of 1 mg per ml
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and behaves, in this condition, as a Th2 clone (Fig 3A, B); however,
the same clone simultaneously secreted IL-4 and IFN-γ, in the presence
of lower doses (, 0.5 mg per ml) of Pen G, whereas IL-4, but not
IFN-γ, was detected in the culture supernatant upon stimulation with
higher Pen G concentrations (Fig 3A, B). It thus appears feasible to
drive the cytokine profile even of established Pen G-reactive T cell
clones, in vitro.
At this stage, it is difficult to envisage simple correlations of these
phenomena with therapeutic applications. Even if the effective in vivo
concentration of the antibiotic could be determined, it will be dictated
by the sensitivity of the invading microorganism rather than by
immunologic side-effects. A closer correlation to possible therapeutic
application might be envisaged from another kind of experiment. We
have used two different penicillin derivatives, Pen V and Amp, which
were not able to induce IL-4 or IFN-γ secretion of clone BAM25
(Fig 3A, B) to antagonise the effect of Pen G on the same clone.
Although Amp did not influence the activity of Pen G, the Pen V
derivative completely shut off the secretion of IFN-γ, without modify-
ing the IL-4 secretion induced by Pen G (Fig 3C, D). The capacity
of this clone to proliferate and secrete IL-2 in the culture supernatant
in response to Pen G, was not dependent on the concentration of
antigen and was not affected in the presence of the nonantigenic
derivatives Pen V and Amp (Padovan and Weltzien, manuscript in
preparation). These data cannot be interpreted simply as another
example of hapten-antagonism as recently described for TNP and
dinitrophenyl in the mouse (Preckel et al, 1997). In our case the effect
is not only specific for very defined combinations of penicillins, but
also results in a highly selective inhibition of only some of the antigen-
induced cellular functions. As penicillins form the major structural
entity of the antigenic determinants contacting the TCR, we believe
that the effects described in Fig 3(C, D) derive from changes in the
early events of TCR-mediated signaling.
Our finding might open new applications in immune intervention,
because, theoretically, the possibility of administrating Pen G in a
cocktail with other penicillins could represent a way to exploit the
immense therapeutic capacity of this drug by limiting its adverse effects.
CONCLUSIONS
The problem of drug allergy is certainly relevant for either clinical or
basic science. In the clinical environment allergic phenomena to drugs
are unpredictable, can induce serious diseases, and clearly restrict the
choice of medication. For basic science, it is certainly fascinating to
understand the molecular mechanism involved in these responses,
which are of low frequency but have very serious consequences. There
is a constant need for diagnostic tests to predict the individual risk of
drug allergy, as well as for assays to predict allergic properties of drugs
(Coleman, 1996).
At this point, it is extremely important to establish a closer collabora-
tion between clinical and basic research laboratories, in order to
achieve, each with its own competence, a better understanding of the
mechanisms involved in drug-induced immune responses and to apply
this knowledge to practical medicine.
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